These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16942658)

  • 41. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
    J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
    Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
    Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
    Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient.
    Henke-Gendo C; Amini-Bavil-Olyaee S; Challapalli D; Trautwein C; Deppe H; Schulz TF; Heim A; Tacke F
    J Infect Dis; 2008 Dec; 198(11):1620-4. PubMed ID: 18847320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral hepatitis in HIV infection.
    Cross TJ; Taylor CB; Harrison PM
    N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17611215
    [No Abstract]   [Full Text] [Related]  

  • 47. The influence of human immunodeficiency virus infection on acute and chronic HBsAg-positive hepatitis.
    Caredda F; Antinori S; Coppin P; Parravicini C; Vago L; Moroni M
    Prog Clin Biol Res; 1991; 364():365-75. PubMed ID: 2020711
    [No Abstract]   [Full Text] [Related]  

  • 48. Tenofovir helpful for patients with HBV.
    AIDS Patient Care STDS; 2005 May; 19(5):347. PubMed ID: 15948275
    [No Abstract]   [Full Text] [Related]  

  • 49. [Presence of HBsAg in lymphocyte cultured from patients infected with human immunodeficiency virus (HIV)].
    Cisterna R; Sarría L; Suñen E; Campelo C; Martínez J; Fernández de Aránguiz A; Gorriño T; Malavé C
    Enferm Infecc Microbiol Clin; 1990 May; 8(5):282-5. PubMed ID: 2090229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acute hepatitis from A virus in carriers of HBsAG superinfected by the hepatitis C virus and the human immunodeficiency virus].
    Aguilera A; Cabarcos A; Prieto A; Regueiro BJ
    Med Clin (Barc); 1992 Oct; 99(13):516-7. PubMed ID: 1434980
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.
    Ida S; Tachikawa N; Nakajima A; Daikoku M; Yano M; Kikuchi Y; Yasuoka A; Kimura S; Oka S
    Clin Infect Dis; 2002 Feb; 34(3):379-85. PubMed ID: 11774086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cluster of fulminant hepatitis B in crack users.
    Comer GM; Mittal MK; Donelson SS; Lee TP
    Am J Gastroenterol; 1991 Mar; 86(3):331-4. PubMed ID: 1998315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Delta agent].
    Slama JL
    Ann Gastroenterol Hepatol (Paris); 1985; 21(5):295-8. PubMed ID: 4083817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards a vaccine for the prevention of hepatitis delta virus superinfection in HBV carriers.
    Ponzetto A; Eckart M; D'Urso N; Negro F; Silvestro M; Bonino F; Wang KS; Chien D; Choo QL; Houghton M
    Prog Clin Biol Res; 1993; 382():207-10. PubMed ID: 8502681
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical aspects and outcome of chronic persistent hepatitis B during hepatitis A virus and delta virus superinfections].
    Nikiforov ND; Il'inskiĭ IuA; Trofimova MN; Borisov VA; Dvurechenskaia GS; Nikiforova GS; Saiapina ES; Kurbanov FK
    Klin Med (Mosk); 1990 Mar; 68(3):50-4. PubMed ID: 2370754
    [No Abstract]   [Full Text] [Related]  

  • 56. [Perinatal co-infection with hepatitis B and HIV viruses--reciprocal effect of the disease and the treatment].
    Soen-Grisaru G; Barzilai A
    Harefuah; 1999 May; 136(10):763-4, 844. PubMed ID: 10955107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging co-infection of HIV and hepatitis B virus in far western Nepal.
    Poudel KC; Jimba M; Okumura J; Wakai S
    Trop Doct; 2006 Jul; 36(3):186-7. PubMed ID: 16884638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fulminant liver failure from acute HCV superinfection in a patient with HIV, HBV, and HDV coinfections.
    Lee K; Smith PT
    AIDS Read; 2000 Jul; 10(7):398, 401. PubMed ID: 10932838
    [No Abstract]   [Full Text] [Related]  

  • 59. Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
    Ingiliz P; Krznaric I; Obermeier M
    AIDS; 2013 Feb; 27(4):667-8. PubMed ID: 23364445
    [No Abstract]   [Full Text] [Related]  

  • 60. Relations between hepatitis delta virus pathogenicity and hepatitis B virus heterogeneity.
    Brunetto MR; Giarin MM; Rosina F; Smedile A; Mangia A; Oliveri F; Abate ML; Piantino P; Manzini P; Calvo PL
    Prog Clin Biol Res; 1993; 382():213-9. PubMed ID: 8502684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.